Tuesday, 20 Aug 2019

Autoimmune/Lupus

Datesort ascending Type Title Save
18 Dec 2018 News TIF1-Ab in Dermatomyositis Linked to Higher Cancer Risk
15 Dec 2018 Social Bing Bingham MD talking on immune related adverse events (MSK and autoimmune). Says these occur in 3-5% of cancer pts treated with Checkpoint inhibitors. Unofficial surveys show nearly 50% of Rheums have seen these referrals. #MARS #ARTHROS https://t.co/yZHMQjpMz8
11 Dec 2018 News Genetic Diagnosis for Previously Undiagnosed Disorders
11 Dec 2018 Social Registry studies of systemic sclerosis shows that early severe GI involvement (9% at 2yrs) is associated with increase risk of inflammatory myositis (OR 4.68), telangiectasias (OR 2.45), skin progression and a >2-fold risk of death (HR 2.27) https://t.co/6e96TldL2S
10 Dec 2018 News SLE and Risk of Malignancy
10 Dec 2018 Social Full text overview of novel biologic and molecular targets studied or in development for SLE. https://t.co/7SGzKNm4Aa https://t.co/ki5toh6O3P
10 Dec 2018 Social Galectin-9 is a biomarker correlating with type 1 IFN signature and correlates w/ disease activity in SLE and and antiphospholipid syndrome and may also correlate with other autoimmune Dz - Sjögren’s, systemic sclerosis & juvenile) dermatomyositis https://t.co/TfpwMAIaaI
06 Dec 2018 News The Benefits of a Lupus Clinic
27 Nov 2018 News Diagnosing Early Lupus from Mimics
27 Nov 2018 Social Musculoskeletal/Rheumatic diseases (arthralgias, myalgias, arthritis, PMR, myositis, Sjogrens, SLE) are uncommon side effects of immune checkpoint inhibitors, so-called irAE (immune related adverse events). Good review here. https://t.co/R52SW0HUjv
26 Nov 2018 News High CV Risk in Lupus
19 Nov 2018 News AURA-LV Trial - Voclosporin Effective in Lupus Nephritis
15 Nov 2018 News Pilot Data on Rituximab in Henoch-Schonlein Purpura
14 Nov 2018 News Scleroderma Expert Treatment Preferences
06 Nov 2018 News IgG4-Related Disease: First Draft Criteria Presented at ACR 2018
01 Nov 2018 Social Big news? Presented at #ACR18 as an abstract (L10) - small study of 29 primary Sjogrens syndrome pts - 8 Placebo vs 21 on Leflunomide + HCQ. At 24 weeks 1/9 PBO and 9/21 LEF/HCQ responded w/ ESSDAI improved > 3. Surprising, small, needs repeating https://t.co/xC4rA1JFIb
31 Oct 2018 Social Nationwide Inpatient Database (2005-2014) studied 2036 SLE patients with MI (STEMI and NonSTEMI) and showed hospital outcomes (Mortality, CABG, AE, hosp stay, costs) same as non-SLE patients. https://t.co/VpOrNh1fq0
26 Oct 2018 Social RT @Rheumforall: Remember cutaneous lupus can be caused by medication. This changes our treatment. https://t.co/UQZE65aOFk
25 Oct 2018 Social RT @MissbeeMD: IgG4-related disease... almost completely unknown 10 years ago. "It is a perfect disease for rheumatologists to take care of…
25 Oct 2018 Social RT @WIRheum: Toci in SSc failed to achieve primary endpoint (modified Rodman skin score) Abs 898 Roundup - Cush, Kavanaugh #ACR18 @Rheum…